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Abstract
In women, establishment of pregnancy is dependent upon ‘fine-tuning’ of the endometrial 
microenvironment, which is mediated by terminal differentiation (decidualisation) of 
endometrial stromal fibroblasts (ESFs). We have demonstrated that intracrine steroid 
metabolism plays a key role in regulating decidualisation and is essential for time-
dependent expression of key factors required for endometrial receptivity. The primary aim 
of the current study was to determine whether sulphated steroids can act as precursors to 
bioactive sex steroids during decidualisation. We used primary human ESF and a robust in 
vitro model of decidualisation to assess the expression of genes associated with sulphation, 
desulphation and transport of sulphated steroids in human ESF as well as the impact of 
the steroid sulphatase (STS) inhibitor STX64 (Irosustat). We found evidence for an increase 
in both expression and activity of STS in response to a decidualisation stimulus with 
abrogation of oestrone biosynthesis and decreased secretion of the decidualisation marker 
IGFBP1 in the presence of STX64. These results provide novel insight into the contribution 
of STS to the intracrine regulation of decidualisation.
Introduction
Decidualisation is a fundamental process of endometrial 
remodelling that is required for the establishment of 
pregnancy. It is associated with unique time-dependent 
transcriptomic and proteomic changes (reviewed in 
Gellersen & Brosens 2014), which are reported to be 
disordered in women with recurrent implantation failure 
(Ruiz-Alonso et  al. 2013, Koot et  al. 2016). Whilst the 
post-ovulatory rise in progesterone acts as an endocrine 
signal to stimulate decidualisation of oestrogen-primed 
human endometrial stromal fibroblast (hESF) (reviewed 
in Gellersen & Brosens 2014), we have demonstrated an 
important role for local (intracrine) steroid metabolism 
in fine-tuning the cellular differentiation of hESFs 
(Gibson et  al. 2016b). Importantly, we have established 
that expression of CYP19A1 (aromatase, the key enzyme 
required for conversion of androgens to estrogens) as well 
as AKR1C3 and SRD5A1 (enzymes that convert precursor 
androgens into testosterone and dihydrotestosterone 
(DHT), respectively) are altered in a time-dependent 
manner (Gibson et al. 2013, 2016a). Expression of these 
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enzymes results in increased biosynthesis of potent steroid 
receptor agonists (E2, testosterone, DHT) that in turn 
regulate the expression of genes important for receptivity 
and immune-cell-mediated vascular remodelling (Gibson 
et al. 2013, 2015, 2016a).
Bioavailability of sulphated steroids can affect intra-
tissue concentrations of oestrogens and androgens, which 
may play a major role in regulating the function of both 
normal and malignant tissues (Mueller et  al. 2015). 
Hydrolysis of sulphated precursors into biologically active 
steroids requires the enzyme steroid sulphatase (STS) 
(Fournier & Poirier 2009). STS primarily converts oestrone 
sulphate (E1S) to oestrone (E1) and is expressed in many 
tissues, albeit at low levels (Miki et  al. 2002, Suzuki et  al. 
2003). In addition to oestrogen-forming activities, STS also 
has the capacity to hydrolyse DHEAS to DHEA, which may 
also act as a precursor for the formation of oestrogens and 
androgens within target tissues (Purohit et  al. 2011). The 
actions of STS are countered by sulphotransferases that 
promote inactivation and metabolism of steroids following 
conjugation of a sulphate moiety. Sulphotransferases 
are a diverse gene family and the isozymes SULT1A1, 
SULT1E1, SULT2A1 and SULT2B1 have been associated 
with sulphation of steroids (Mueller et al. 2015). SULT1E1 
primarily catalyses the sulphation of oestrogens, although 
SULT1A1 is also reported to have this action (Gamage et al. 
2005). Sulphation requires the co-substrate PAPS (adenosine 
3′-phosphate 5′-phosphosulfate) that provides the universal 
sulphate donor compound for all sulphotransferase 
reactions. PAPS is synthesised via one of two PAPS synthase 
isoforms PAPSS1 and PAPSS2 (Schroder et al. 2012). Uptake 
and excretion of sulphated steroids from cells is regulated by 
membrane transporters which are reported to be expressed 
in endometrial and ovarian cancer cells and tissues (Mueller 
et  al. 2015, Rizner et  al. 2017). To date, few studies have 
examined the expression of STS, sulphotransferases, PAPSS 
or membrane transporters in endometrial tissues. 
STS immunoexpression has been detected in both 
stromal and epithelial cells in the endometrium across the 
menstrual cycle (Dassen et al. 2007). In a study using 12 
endometrial cancer samples and adjacent endometrium, 
expression of both STS and SULT1E1 mRNAs were higher 
in the normal endometrium than in the malignant cells 
(Smuc et  al. 2006). Notably, in both benign and normal 
endometrial tissues, concentrations of mRNAs for STS were 
higher than SULT1E1 (Smuc et al. 2006), which may favour 
an increase in the bioavailability of active steroid receptor 
agonists in the endometrium. Indeed, studies using STX64 
(Irosustat), an irreversible inhibitor of STS (Day et al. 2009), 
suggest that STS can regulate formation of oestradiol (E2) 
in the uterus (Colette et al. 2011). STS inhibitors are also 
reported to decrease the oestrogenic growth of hormone-
dependent tissues, including endometrial cancer tissues 
(Foster et al. 2008) and proliferation of human endometrial 
xenografts (Colette et  al. 2011). Recently, Sinreih et  al. 
extended their studies on endometrial cancer steroid 
intracrinology and concluded that E2 was formed from E1S 
via the sulphatase pathway rather than via aromatase in 
endometrial cancer tissues (Sinreih et al. 2017). In contrast, 
previous studies in both human and mouse suggest 
intracrine regulation of the normal endometrium occurs 
via aromatase-dependent biosynthesis of oestrogens (Das 
et al. 2009, 2012, Gibson et al. 2013).
In the current study, we sought to complement and extend 
our previous investigations by assessing the contribution of 
STS to intracrine regulation of decidualisation. We used an 
in vitro model of decidualisation to assess the expression 
of genes associated with sulphation, desulphation and 
transport of sulphated steroids in hESFs and assessed the 
impact of the STS inhibitor STX64 (Irosustat). Our results 
provide new insight into the mechanisms that contribute to 
generation of an oestrogen-rich microenvironment during 
the establishment of pregnancy.
Materials and methods
Human studies
Primary human endometrial tissue (proliferative phase, 
n = 9) was obtained from women undergoing surgery for 
non-malignant gynaecological conditions. None of the 
women were receiving hormonal therapy or suffering 
from endometriosis. Primary hESFs were isolated from 
proliferative phase endometrium and cycle phase 
determined as reported previously (Bombail et al. 2010). 
Briefly, endometrial tissue was minced using scalpel blades, 
followed by DNAse/collagenase digest for 2 h at 37°C. The 
tissue homogenate was then sequentially strained through 
70 µm and 40 µm membrane filters to separate hESF from 
the glandular epithelium. Isolated hESFs were washed in 
warmed PBS and cultured in RPMI 1640, supplemented 
with 10% foetal calf serum (FCS) at 37°C in 5% CO2 and 
maintained for a maximum of five passages. Forty-eight 
hours prior to experimentation, hESF culture media were 
changed to phenol red-free RPMI 1640 supplemented 
with 10% charcoal-stripped FCS (CSFCS). Decidualisation 
was induced by addition of decidualisation (DEC) media 
(phenol red-free RPMI 1640, 2% CSFCS, 0.1 mg/mL 
8-Br-cAMP (Sigma, B5386), 1 µM progesterone (Tocris, 
Abingdon, UK; Cat no. 2835)). Some cell cultures were 
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supplemented with the STS inhibitor Irosustat (STX64; 
10 µM, Sigma S1950) for the duration of the culture 
period. Control cultures were incubated with phenol 
red-free RPMI 1640, 2% CSFCS and equivalent volume 
of vehicle control (DMSO). 2 × 105 hESFs were seeded per 
well of six-well plate, treatments were in duplicate and 
assessed in minimum of three individual patients for all 
treatments. For experiments assessing expression and 
activity of sulphation enzymes/transporters, cells from 
n = 6 patients were assessed. For experiments assessing the 
impact of STX64, cells from n = 3 patients were used. Each 
sample was assayed in duplicate and average values were 
analysed. To assess the time-dependent accumulation of 
secreted products, treatments were maintained for the 
duration of each time point. hESFs were treated for 24 h 
(1 day), 48 h (2 days), 4 days or 8 days as indicated; cells 
were treated in parallel with dedicated samples for each 
time point and patient. The expression of genes associated 
with sulphation, desulphation and transport of sulphated 
steroids was assessed by RT-qPCR.
Assessment of mRNA
Isolation of mRNAs, preparation of cDNAs and analysis 
by RT-qPCR was performed according to standard 
protocols (Bombail et  al. 2010); samples were analysed 
by the comparative ΔΔCt method with CYC (cyclophilin) 
as an internal control. Primers/probes are given in 
Supplementary Table  1 (see section on supplementary 
data given at the end of this article).
ELISA
Insulin-like growth factor-binding protein 1 (IGFBP1), E1 
and E2 in culture supernatants were determined by ELISA 
as described previously (Gibson et al. 2013, 2016a). E1 and 
E2 were not detected in control supernatants (not shown). 
Antibody cross-reactivity for E1 and E2 ELISA was <5% for 
other steroids (Supplementary Tables 2 and 3).
Measurement of steroid sulfatase activity
STS activity was determined in cell lysates as described 
previously (Purohit et al. 1997). Briefly, cells were lysed in 
RIPA buffer and protein concentration measured by BCA 
assay. Hundred micrograms of protein were incubated for 
4 h with PBS containing [6,7-3H] E1S (4 × 105 dpm) adjusted 
to a final concentration of 20 μM with unlabelled E1S. 
[4-14C] E1 (1 × 104 dpm) was used to monitor procedural 
losses. E1 was separated from E1S by toluene partition 
and 3H and 14C radioactivity was measured by liquid 
scintillation spectrometry. Results were expressed as E1 
formed pmol/h/mg protein.
Statistics
Statistical analysis was performed using GraphPad prism. 
Two-way ANOVA was used to determine the significance 
between treatments in grouped data; interaction between 
time and treatment was assessed, Sidak’s multiple 
comparisons test was used to assess the differences between 
treatments for individual time points. Non-parametric 
testing was utilised where sample sizes were insufficient 
to confirm normality of data distribution; Mann–Whitney 
test was used to assess differences between treatments at 
each time point for RT-qPCR data. Criterion for significance 
was P < 0.05. All data are presented as mean ± s.e.m.
Study approval
Written informed consent was obtained from all subjects 
prior to surgery; ethical approval was granted by the 
Lothian Research Ethics Committee (LREC/07/S1103/29 
and LREC 10/S1402/59). Methods were carried out 
in accordance with NHS Lothian Tissue Governance 
guidelines. Studies using these cells have previously been 
reported in (Gibson et al. 2018).
Results
Expression of sulphation and desulphation enzymes 
during decidualisation of human ESF
We assessed expression of STS as well as members of the 
sulphotransferase gene family in cells recovered 1–8 days 
after incubation with control (VC) or DEC culture media 
(Figs 1 and 2). Expression of STS was increased at all time 
points in hESF stimulated with DEC; results reached 
statistical significance in samples recovered on Day 1 
(Fig. 1A; n = 6; P < 0.0001), 2 (Fig. 1B; n = 6; P < 0.0001) and 4 
(Fig. 1C; n = 6; P < 0.01). To complement these findings, STS 
activity was assessed in cell lysates and was significantly 
increased in lysates from hESF treated with DEC media 
compared to VC after 4 days of treatment (Fig. 1E, n = 6; 
P < 0.05).
To determine whether E1 and E2 formed by 
decidual cells (Gibson et  al. 2013) might also be 
subject to inactivation, we also assessed expression 
of sulphotransferases in the same samples. In these 
experiments, expression of SULT1E1 and SULT2A1 mRNAs 
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were not detected (not shown). In contrast, mRNAs 
encoded by SULT1A1 and SULT2B1a were present (Fig. 2A 
and B). SULT1A1 mRNAs were significantly increased in 
hESF stimulated with DEC media compared to VC after 1 
(n = 6; P < 0.01), 2 (n = 6; P < 0.001) and 8 days (n = 6; P < 0.05) 
of culture. SULT2B1a mRNAs were significantly increased 
on days 1 (n = 6; P < 0.0001) and 2 (n = 6; P < 0.01) of culture, 
however, by day 8, this was reversed with a significant 
decrease detected in DEC compared to VC-treated hESF 
(n = 6; P < 0.05).
Expression of PAPSS isozymes during 
decidualisation of hESF
To complement and extend the studies on 
sulphotransferase enzymes, we also assessed expression of 
PAPSS isozymes PAPSS1 and PAPSS2. Expression of mRNAs 
encoded by PAPSS1 (Fig. 3A) was increased in DEC-treated 
hESF compared to controls on days 1 (n = 6; P < 0.05) and 
8 (n = 6; P < 0.01), whereas PAPSS2 mRNA concentrations 
were only higher on day 1 (n = 6; P < 0.01) and unchanged 
at other time points (Fig. 3B).
Expression of ATP-binding cassette transporters 
during decidualisation of human ESF
We assessed expression of cellular transporters ABCC1 
and ABCC4, which are associated with efflux of sulphated 
steroids. Expression of mRNAs encoding ABCC1 was 
increased in a time-dependent manner in decidualised 
hESF (Fig. 4A). ABCC1 mRNA expression was significantly 
increased in DEC compared to controls at each time 
point; 1 (n = 6; P < 0.0001), 2 (n = 6; P < 0.0001) and 4 (n = 6; 
P < 0.01) days, with the greatest increase in expression 
detected after 8  days (n = 6; P < 0.0001). In contrast, 
ABCC4 mRNA expression was significantly decreased 
in hESF treated with DEC compared to controls at 2 
(n = 6; P < 0.01), 4 (n = 6; P < 0.0001) and 8 (n = 6; P < 0.01) 
days (Fig.  4B). Expression of organic anion-transporting 
Figure 1
Expression and activity of STS during decidualisation. HESFs were treated 
with either VC or DEC for 1–8 days as indicated and mRNAs encoding STS 
were assessed by RT-qPCR. STS mRNA was significantly increased in hESF 
treated with decidualisation media for 1, 2 and 4 days compared to VC 
but not different at the 8-day time point (A, B, C and D; N = 6 patients, 
duplicate treatments; Mann–Whitney test.). STS activity was assessed in 
hESF (E) and was increased in cells treated with DEC compared to VC after 
4 days (P < 0.05; n = 6 patients, one-way ANOVA). *P < 0.05; **P < 0.01; 
****P < 0.0001. DEC, decidualisation media; HESF, human endometrial 
stromal fibroblasts; STS, steroid sulphatase; VC, vehicle control.
Figure 2
Expression of sulphation enzymes during 
decidualisation. HESFs were treated with either 
VC or DEC for 1–8 days as indicated and mRNAs 
encoding SULT2B1 transcript variant 1 (SULT2B1a) 
and SULT1A1 were assessed by RT-qPCR. (A) 
SULT1A1 mRNA was significantly increased at 1, 2 
and 8 days in hESF treated with DEC compared to 
VC. (B) SULT2B1a mRNA was significantly 
increased after 1- and 2-day treatment with DEC 
but by 8 days was significantly decreased 
compared to VC treatment. Expression of SULT1E1 
and SULT2A1 was not detected (not shown). n = 6 
patients, duplicate treatments. Mann–Whitney 
test. *P < 0.05; **P < 0.01; ***P < 0.001; 
****P < 0.0001. DEC, decidualisation media; HESF, 
human endometrial stromal fibroblasts; VC, 
vehicle control.
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polypeptide transporters (SLC gene family; SLCO1A2, 
SLCO1B1, SLCO1B3 and SLCO2B1), which mediate influx 
of sulphated steroids were not detected in either control 
or decidualised hESF (not shown).
In light of these results and as a complement to our 
previous studies in which we demonstrated that both E1 and 
E2 are secreted into culture media during our decidualisation 
protocol (as determined by ELISA (Gibson et al. 2013)), we 
used sensitive LC-MS to assess the concentrations of E1S 
or E2S in conditioned media from hESF, however, neither 
steroid was detected in either the control or DEC samples 
(not shown; LLOD for E1S and E2S = 0.5 ng/mL).
Irosustat (STX64) disrupts bioavailability of 
oestrogens and alters decidualisation responses
We investigated the potential importance of STS activity 
during decidualisation of hESF by assessing the impact of 
the selective, irreversible STS inhibitor Irosustat (STX64). 
hESFs were stimulated with DEC media or co-incubated 
with STX64 (DEC STX) for 1, 2, 4 or 8 days. Incubation 
with STX64 was associated with altered production of 
oestrogens from hESF and mean concentrations of secreted 
E1 were decreased at each time point in hESF treated with 
DEC STX compared to DEC alone (Fig. 5A). The impact of 
STX on E1 secretion was time-dependent with the greatest 
reduction detected after 1 day (32% decrease in E1; n = 3 
patients, P < 0.05) but at later time points, there was no 
significant difference between hESF treated with DEC and 
DEC STX. In contrast to E1, concentrations of secreted 
E2 were not altered between hESF treated with either 
DEC alone or DEC STX (Supplementary Fig. 1). We next 
assessed if altered bioavailability of oestrogens affected 
decidualisation of hESF. Notably, STX64 altered secretion 
of the decidualisation marker IGFBP1; with concentrations 
reduced at each time point and significantly decreased 
after 1 day in hESF treated with DEC STX compared to 
DEC alone (Fig. 5B, n = 3 patients, P < 0.05).
Discussion
Oestrogens within tissues can be derived from two 
pathways; de novo synthesis, which requires aromatase, and 
activation of circulating sulphated steroids which requires 
Figure 3
Expression of PAPSS isozymes during 
decidualisation. HESF were treated with either VC 
or DEC for 1–8 days as indicated and mRNAs 
encoding PAPSS1 and PAPSS2 were assessed by 
RT-qPCR. (A) PAPPS1 mRNA was significantly 
increased at 1 and 8 days in hESF treated with 
DEC compared to VC while PAPSS2 mRNA (B) was 
increased only after 1 day. n = 6 patients, 
duplicate treatments. Mann-Whitney test. 
*P < 0.05; **P < 0.01. DEC, decidualisation media; 
HESF, human endometrial stromal fibroblasts; 
PAPSS, adenosine 3′-phosphate 5′-phosphosulfate 
synthase; VC, vehicle control.
Figure 4
Expression of ATP-binding cassette transporters 
during decidualisation. HESFs were treated with 
either VC or DEC for 1–8 days as indicated and 
mRNAs encoding ABCC1 and ABCC4 were 
assessed by RT-qPCR. (A) ABCC1 mRNA increased 
in a time-dependent manner and was 
significantly increased in hESF treated with 
decidualisation media for 1, 2, 4 and 8 days 
compared to VC. (B) ABCC4 mRNA decreased in a 
time-dependent manner and was significantly 
decreased after 2, 4 and 8 days of treatment with 
DEC compared to VC. Expression of mRNAs 
encoding the organic anion transporters 
SLCO1A2, SLCO1B1, SLCO1B3 and SLCO2B1 
SULT1E1 were not detected. n = 6 patients, 
duplicate treatments. Mann–Whitney test. 
**P < 0.01; ***P < 0.001; ****P < 0.0001. DEC, 
decidualisation media; HESF, human endometrial 
stromal fibroblasts; VC, vehicle control.
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STS (Simpson et  al. 1994, Mueller et  al. 2015). While de 
novo oestrogen synthesis via aromatase has emerged as 
a key steroidogenic process in the normal endometrium 
(Das et  al. 2009, 2012, Gibson et  al. 2013), activation of 
sulphated steroids via STS is reported to be a prominent 
mechanism of oestrogen activation in pathologies of 
the endometrium including endometrial cancer and 
endometriosis (Colette et al. 2011, Sinreih et al. 2017). To 
date, the literature supports that aromatase-dependent 
de novo synthesis of oestrogens is essential for intracrine 
regulation of endometrial function. Das et  al. provided 
the first evidence that de novo synthesis of oestrogens was 
required for decidualisation (Das et al. 2009). Using a mouse 
model, they showed that following ovariectomy on day 5 
of pregnancy, supplementation with progesterone was 
sufficient to maintain the decidualisation response as well 
as growth and development of implanted embryos, (Das 
et  al. 2009). However, in the presence of the aromatase 
inhibitor letrozole, both decidualisation and implantation 
were impaired indicating that ovarian oestrogens were 
dispensable for decidualisation (Das et al. 2009). In further 
experiments using a mouse model of artificially induced 
decidualisation, they went on to show that factors required 
for stromal remodelling and neovascularisation were 
dependent on aromatase-dependent intrauterine de novo 
biosynthesis of oestrogens (Das et  al. 2009, 2012). Our 
recent studies have extended these observations in mice and 
found evidence for complementary mechanisms in human 
endometrial stromal fibroblasts. We have shown that hESF 
have the capacity to utilise DHEA as a substrate and that hESF 
synthesise aromatisable androgens during decidualisation 
(Gibson et al. 2013, 2016a, 2018). We have demonstrated 
that decidualisation is characterized by an increase in 
the expression and activity of aromatase (CYP19A1) 
leading to local biosynthesis of both E1 and E2 within the 
microenvironment of the endometrial stroma (Gibson et al. 
2013). We have also demonstrated that oestrogens regulate 
cellular cross-talk within the endometrium during the 
establishment of pregnancy by directly regulating immune 
cell function and promoting vascular remodelling (Gibson 
et al. 2015). Given that oestrogens play such an essential role 
in modulating the endometrial environment, in the present 
study, we sought to further examine the mechanisms that 
regulate the availability of oestrogens by assessing the 
contribution of STS to intracrine oestrogen bioavailability 
during decidualisation.
We speculated that in addition to the classic de novo 
biosynthesis pathway, oestrogens may also be synthesised 
via de-sulphation of E1S. Using a robust model of in 
vitro decidualisation and hESF, we detected increased 
expression and activity of STS. Notably, we found that 
the STS inhibitor STX64 (Irosustat) had a time-dependent 
impact on decidualisation and decreased secretion of IGFBP1 
from days 1 to 4 of the time course. Decreased secretion 
of IGFBP1 was associated with concomitant decreases in 
E1 concentrations suggesting STS-dependent regulation 
of intracrine oestrogens occurs during decidualisation. 
Notably, the aromatase inhibitor letrozole is reported 
to completely inhibit uterine oestrogen production in 
ovariectomised mice (Das et  al. 2009). However, in our 
previous study, we co-incubated hESF with the aromatase 
inhibitor letrozole during decidualisation, and this only 
reduced secretion of E1 and E2 by approximately 65% 
(Gibson et al. 2013). In the current study, E1 synthesis was 
reduced by up to 30% during decidualisation consistent 
with both STS- and aromatase-dependent production of E1 
Figure 5
Irosustat (STX64) disrupts oestrogen bioavailability and alters 
decidualisation responses. The impact of the potent irreversible STS 
inhibitor STX64 (STX) on decidualisation of hESF was investigated 
following treatment for 1–8 days as indicated. (A) Secretion of E1 was 
significantly decreased after 1 day in hESF treated with DEC + STX 
compared to DEC alone (P < 0.05). Two-way ANOVA; global analysis time 
factor P = 0.0158, treatment factor P = 0.0111. Sidak’s multiple 
comparisons test; treatment effect significantly different day 1 P < 0.05. 
(B) Concentrations of IGFBP1 tended to be lower at all time points in hESF 
treated with DEC + STX compared to DEC alone. STX significantly 
decreased secretion of the decidualisation marker IGFBP1 after 1 day of 
treatment (P < 0.05). Two-way ANOVA; global analysis time factor 
P = 0.0026, treatment factor P = 0.0008. Sidak’s multiple comparisons test; 
treatment effect significantly different day 1 P < 0.05. E1 and IGFBP1 
secretion was determined by ELISA. n = 3 patients, duplicate treatments. 
*P < 0.05. DEC, decidualisation media; E1, oestrone; HESF, human 
endometrial stromal fibroblasts; IGFBP1, insulin-like growth factor-
binding protein-1.
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during decidualisation. Notably, the effect of STX64 on E1 
concentrations was most pronounced at day 1 but absent 
by day 8. This reflects our previous observations regarding 
the role of intracrine sex steroids during decidualisation, 
whereby modulation of local androgen action resulted 
in time-dependent changes in the expression of 
decidualisation and implantation-associated factors in 
the presence of the antiandrogen flutamide (Gibson et al. 
2016a). Thus, if sulphated oestrogens are contributing to 
the ‘oestrogen pool’ during decidualisation, this effect may 
also be temporally regulated, with increased de-sulphation 
of steroid precursors during the early stages of 
decidualisation preceding aromatase-dependent synthesis 
of oestrogens during the latter stages of the differentiation 
process. Our results therefore suggest sulphation pathways 
contribute to regulation of decidualisation via rapid as 
well as gradual mechanisms. Taken together, our findings 
suggest bioavailability of intracrine oestrogens modulates 
initiation of stromal decidualisation and that tightly 
controlled regulation of intracrine steroids, via sulphation 
and export, is required as decidualisation progresses for 
appropriate paracrine signalling to immune and vascular 
endothelial cells within the tissue microenvironment 
during endometrial remodelling. 
Notably, the most abundant oestrogen detected in the 
current analysis and in our previous study (Gibson et al. 2013) 
was E1. This was surprising as E1 is classically considered 
to be weak/inactive oestrogen. However, our results are 
consistent with Huhtinen et al. who performed intra-tissue 
profiling of human endometrial tissues using LC-MS. They 
reported increased concentrations of E1 in secretory phase 
endometrium compared to serum concentrations and that 
mean intrauterine concentrations of E1 are greater than E2 
in the secretory phase (Huhtinen et al. 2012). Although the 
role of E2 in regulating establishment of pregnancy is well 
established, the predominance of E1 in the intrauterine 
environment during the secretory phase may suggest 
an independent role for E1 in regulating endometrial 
function. We have previously demonstrated that equimolar 
concentrations of E1 (10 nM) can directly regulate increases 
in ER-dependent migration of uterine NK cells to a similar 
extent as E2 (Gibson et al. 2015) and in the current study, 
it was notable that reduction of E1 concentrations but not 
E2 by STX64 abrogated secretion of the decidualisation 
marker IGFBP1. Whether E1 acts as a direct agonist or by 
modulating intracrine metabolism in this context requires 
further investigation. However, the findings in the current 
study provide new evidence that availability of E1 may 
independently contribute to regulation of the endometrial 
microenvironment.
Sulphation of steroids is a primary route for 
metabolism of active oestrogens in healthy peripheral 
tissues. Previous studies have demonstrated that mRNA 
expression of the main oestrogen sulphating enzyme 
SULT1E1 is detected at all stages of the menstrual cycle 
in total endometrial tissue extracts (Dassen et al. 2007). 
In the current study, SULT1E1 was not detected in hESF, 
consistent with classic metabolism studies, which only 
detected formation of E1S from isolated endometrial 
epithelial, but not stromal, cells following incubation with 
E2 (Liu & Tseng 1979). We did detect mRNA expression 
of SULT1A1 which is reported to be expressed in the 
endometrium (Rubin et al. 1999) and also has oestrogen 
sulphating activity (Falany & Falany 1996), albeit in the 
micromolar range. Notably, increased concentrations of 
sulphotransferases (SULT1A1, SULT2B1) were detected 
concurrent with increased expression of PAPSS isozymes; 
however, we could not detect any sulphated oestrogens 
in conditioned media from hESF. There are limited data 
on the expression of transmembrane transporters that 
mediate cellular influx and efflux of sulphated steroids 
in the endometrium. Nishimura and Naito assessed 
mRNA expression of 46 ABC transporters and 108 SLC 
transporters in a range of tissues including 3 human 
uterine samples (Nishimura & Naito 2005). Notably, 
relative expression of mRNAs (ratio of target genes to 
PPIA housekeeping gene) encoding SLCO1A2, SLCO1B1 
and SLCO2B1 as well as ABCC1 and ABCC4 were reported 
in uterine samples; although expression of SLC isoforms 
was relatively low compared to other tissues (Nishimura 
& Naito 2005). In the current study, we could not detect 
expression of SLC isoforms in hESF, however, ABC 
transporters (ABCC1 and ABCC4) were detected and 
dynamically regulated consistent with a possible role 
in export of sulphated steroids during decidualisation. 
It is a limitation of the current study that only the 
contribution of stromal compartment was assessed. 
Given the reported expression and activity of SULT1E1 
in endometrial epithelial cells (Liu & Tseng 1979), further 
studies are needed to assess the contribution of epithelial 
cells and stromal–epithelial interactions in regulating 
oestrogen bioavailability within the endometrium. Our 
data support STS activity is prominent in the stromal 
compartment during decidualisation and additionally 
we found some evidence for time-dependent increases 
in expression of sulphotransferase enzymes. We did 
not detect any secretion of sulphated oestrogens in 
conditioned medium for hESF, which may suggest that 
any sulphated oestrogens formed during decidualisation 
are subject to direct hydrolysis by STS.
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In our study, we used primary human cells and a 
well-characterised model of in vitro decidualisation; 
however, it is conceivable that adaptive metabolism and 
alternative pathways may be more prominent in disease 
states such as endometriosis and endometrial cancer 
where increased expression of STS has been reported 
(Utsunomiya et  al. 2004, Piccinato et  al. 2016, Sinreih 
et  al. 2017). It is notable that balanced availability of 
oestrogens is required to regulate establishment of 
pregnancy. Increasing or decreasing E2 outside the normal 
physiological range is detrimental to implantation in mice 
(Ma et  al. 2003). Furthermore, supraphysiological levels 
of E2 and progesterone as a result of controlled ovarian 
hyperstimulation during in vitro fertilization treatment 
protocols is associated with low implantation rates, 
possibly as a result of an altered steroid milieu (Pellicer 
et  al. 1996). ‘Out of phase’ endometrial remodelling is 
a common feature of implantation failure but whether 
dysregulation of endometrial intracrine metabolism 
occurs in sub/infertility requires further investigation. 
Notably, drugs that target steroid metabolism such 
as aromatase inhibitors, STS inhibitors, DASI (dual 
aromatase–STS inhibitors) and 17BHSD1 inhibitors may 
affect endometrial function, and these potential actions 
should be considered in future therapeutic applications of 
these drugs in reproductive-aged women.
Conclusions
In the current study, we assessed the expression of 
sulphation and desulphation enzymes, sulphate donors 
and transmembrane transporters in hESFs during a 
time course of in vitro decidualisation. We found that 
inhibition of STS activity disrupted bioavailability of 
oestrogens and inhibited decidualisation responses 
consistent with stromal utilisation of sulphated steroids 
as precursors to active hormones during decidualisation. 
Elucidation of the complex intracrine metabolism of 
steroids within the endometrium during decidualisation 
will be critical to understanding the relevance of these 
findings to reproductive health and disease. The results 
of the current study provide new insight into the 
contribution of sulphated steroids to the regulation 
of decidualisation and expand our understanding of 
intracrine regulation of the endometrium during the 
establishment of pregnancy.
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